Moreover, statistical analysis of The Cancer Genome Atlas database demonstrated that BCYRN1 was strikingly overexpressed in multiple cancers and is associated with poor prognosis of patients (Figures S1A‐S1I). Here, BCYRN1 is linked to cancer.